Table 7.

Number of infections for all groups during follow-up (18 mo), after randomisation

InfectionMMF/PredMMF/CsAMMF/CsA/PredP
n patients637673
Viral infectionsNS
    herpes simplex558
    herpes zoster230
    cytomegalovirus412
Opportunistic infectionsNS
    candida stomatitis331
    oesofagitis011
Bacterial infectionsNS
    urinary tract363133
    pneumonia/bronchitis3/23/85/10
    upper respiratory tract131616
    skin763
    gastrointestinal tract433
    other114
Sepsis302NS
Culture-negative infection31210NS
Total859398NS